Business Standard

Centre proposes anti-dumping duty on China antibiotic drug ofloxacin

No impact on end consumer as prices are regulated

drugs, medicines, USFDA
Premium

Directorate General of Trade Remedies (DGTR) has recommended the duty on imports of ‘ofloxacin’ and its intermediates from China after concluding in its probe that the product has been exported at dumped prices into India, which impacted the domestic

Sohini DasPTI Mumbai
The commerce ministry has recommended imposition of anti-dumping duty on Chinese ofloxacin — a medicine used to treat certain infections — for five years to guard domestic players from cheap imports from the neighbouring country.

The move will not impact the end consumer as prices of essential medicines in India are fixed, said an industry source, who added that there will be no change in the medicine price.

“However, if the API is also brought under this anti-dumping, the government is trying to protect the local industry against cheaper imports,” the person said.

Typically, Chinese bulk drugs are cheaper by

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 19 2022 | 8:42 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com